Frontlight ResearchEarly access
Ovarian cancer trials in Tunisia
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peoplePatent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
- Where
- La Rabta
- Age
- 18 years and over
- People
- 30
- Run by
- Faculty of Medicine of Tunis
See details and how to joinNCT07508306